公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2014 | Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells | Lin J.-J.; CHIUN-SHENG HUANG ; Yu J.; Liao G.-S.; HUANG-CHUN LIEN ; Hung J.-T.; Lin R.-J.; Chou F.-P.; Yeh K.-T.; Yu A.L. | Breast Cancer Research | 38 | 31 | |
2016 | MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast | HUANG-CHUN LIEN ; CHIUN-SHENG HUANG ; YA-WEN YANG ; YUNG-MING JENG | APMIS | 11 | 8 | |
1999 | Merkel cell carcinoma and chronic arsenicism | HUANG-CHUN LIEN ; TSEN-FANG TSAI ; Yu Yun Lee, Hsiao C.-H. | Journal of the American Academy of Dermatology | 76 | 50 | |
2000 | Metastatic carcinoma to the jugular foramen | Chao C.-K.; Sheen T.-S.; HUANG-CHUN LIEN ; Hsu M.-M. | Otolaryngology - Head and Neck Surgery | 8 | 5 | |
2007 | Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: Identification of genes potentially related to epithelial-mesenchymal transition | HUANG-CHUN LIEN ; Hsiao Y.H.; Lin Y.S.; Yao Y.T.; Juan H.F.; WEN-HUNG KUO ; Hung M.-C.; KING-JEN CHANG ; FON-JOU HSIEH | Oncogene | 175 | 164 | |
2016 | Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: Implications for pathogenesis and histogenesis | HUANG-CHUN LIEN ; CHIUN-SHENG HUANG ; YA-WEN YANG ; YUNG-MING JENG | Histopathology | 28 | 24 | |
2001 | A novel role of metalloproteinase in cancer-mediated immunosuppression | BOR-CHING SHEU ; Hsu S.-M.; HONG-NERNG HO ; HUANG-CHUN LIEN ; Huang S.-C.; Lin R.-H. | Cancer Research | 261 | | |
2011 | Nuclear ErbB2 enhances translation and cell growth by activating transcription of ribosomal RNA genes | Li L.-Y.; Chen H.; Hsieh Y.-H.; Wang Y.-N.; Chu H.-J.; Chen Y.-H.; Chen H.-Y.; Chien P.-J.; Ma H.-T.; Tsai H.-C.; Lai C.-C.; Sher Y.-P.; HUANG-CHUN LIEN ; Tsai C.-H.; Hung M.-C. | Cancer Research | 58 | 53 | |
2004 | p53 overexpression and mutation in metaplastic carcinoma of the breast: Genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components | HUANG-CHUN LIEN ; CHUNG-WU LIN ; TSUI-LIEN MAO ; SUNG-HSIN KUO ; Hsiao C.-H.; CHIUN-SHENG HUANG | Journal of Pathology | 67 | 63 | |
2020 | The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice | Gonzalez-Ericsson P.I.; Stovgaard E.S.; Sua L.F.; Reisenbichler E.; Kos Z.; Carter J.M.; Michiels S.; Le Quesne J.; Nielsen T.O.; Lænkholm A.-V.; Fox S.B.; Adam J.; Bartlett J.M.S.; Rimm D.L.; Quinn C.; Peeters D.; Dieci M.V.; Vincent-Salomon A.; Cree I.; Hida A.I.; Balko J.M.; Haynes H.R.; Frahm I.; Acosta-Haab G.; Balancin M.; Bellolio E.; Yang W.; Kirtani P.; Sugie T.; Ehinger A.; Castaneda C.A.; Kok M.; McArthur H.; Siziopikou K.; Badve S.; Fineberg S.; Gown A.; Viale G.; Schnitt S.J.; Pruneri G.; Penault-Llorca F.; Hewitt S.; Thompson E.A.; Allison K.H.; Symmans W.F.; Bellizzi A.M.; Brogi E.; Moore D.A.; Larsimont D.; Dillon D.A.; Lazar A.; HUANG-CHUN LIEN ; Goetz M.P.; Broeckx G.; El Bairi K.; Harbeck N.; Cimino-Mathews A.; Sotiriou C.; Adams S.; Liu S.-W.; Loibl S.; I-CHUN CHEN ; Lakhani S.R.; Juco J.W.; Denkert C.; Blackley E.F.; Demaria S.; Leon-Ferre R.; Gluz O.; Zardavas D.; Emancipator K.; Ely S.; Loi S.; Salgado R.; Sanders M. | Journal of Pathology | 132 | 114 | |
2008 | Patterns, Effects, and Thoracic Volume Changes of Thoracoscopic Pleurodesis in Rabbits | JIN-SHING CHEN ; WERN-CHERNG CHENG ; HUANG-CHUN LIEN ; Wu S.-W.; HSAO-HSUN HSU ; Lee S.-C.; Lee Y.-C. | Journal of Surgical Research | 7 | 7 | |
2015 | Phosphorylation of ezh2 at t416 by cdk2 contributes to the malignancy of triple negative breast cancers | Yang C.-C.; Labaff A.; Wei Y.; Nie L.; Xia W.; Huo L.; Yamaguchi H.; Hsu Y.-H.; Hsu J.L.; Liu D.; Lang J.; Du Y.; HUANG-CHUN LIEN ; Li L.-Y.; Deng R.; Chan L.-C.; Yao J.; Kleer C.G.; Hortobagyi G.N.; Hung M.-C. | American Journal of Translational Research | 40 | | |
2020 | Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer | Kos Z.; Roblin E.; Kim R.S.; Michiels S.; Gallas B.D.; Chen W.; van de Vijver K.K.; Goel S.; Adams S.; Demaria S.; Viale G.; Moreira A.M.; Richardson A.; Vingiani A.; Bellizzi A.M.; Guerrero A.; Grigoriadis A.; Garrido-Castro A.C.; Cimino-Mathews A.; Srinivasan A.; Acs B.; Nielsen T.O.; Singh B.; Calhoun B.; Haibe-Kans B.; Solomon B.; Thapa B.; Nelson B.H.; Ballesteroes-Merino C.; Criscitiello C.; Boeckx C.; Colpaert C.; Badve S.S.; Quinn C.; Chennubhotla C.S.; Solinas C.; Drubay D.; Sabanathan D.; Peeters D.; Zardavas D.; Höflmayer D.; Johnson D.B.; Thompson E.A.; Symmans W.F.; Perez E.; ElGabry E.A.; Blackley E.F.; Reisenbichler E.; Chmielik E.; Gaire F.; Lu F.-I.; Azmoudeh-Ardalan F.; Peale F.; Hirsch F.R.; Sotiriou C.; Acosta-Haab G.; Farshid G.; Broeckx G.; Koeppen H.; Haynes H.R.; McArthur H.; Joensuu H.; Olofsson H.; Cree I.; Nederlof I.; Rimm D.L.; Frahm I.; Brcic I.; Chan J.; Ziai J.; Brock J.; Weseling J.; Giltnane J.; Lemonnier J.; Zha J.; Ribeiro J.; Hewitt S.; Lennerz J.K.; Carter J.M.; Hartman J.; Hainfellner J.; Le Quesne J.; Juco J.W.; van den Berg J.; Sanchez J.; Cucherousset J.; Adam J.; Denkert C.; Balko J.M.; Saeger K.; Siziopikou K.; Sikorska K.; Weber K.; Steele K.E.; Emancipator K.; El Bairi K.; Allison K.H.; Korski K.; Loibl S.; Buisseret L.; Shi L.; Kooreman L.F.S.; Molinero L.; Estrada M.V.; Van Seijen M.; Lacroix-Triki M.; Sebastian M.M.; Balancin M.L.; Mathieu M.-C.; Luen S.J.; van de Vijver M.; Rebelatto M.C.; Piccart M.; Goetz M.P.; Preusser M.; Khojasteh M.; Sanders M.E.; Regan M.M.; Barnes M.; Christie M.; Bartlett J.M.S.; Misialek M.; Ignatiadis M.; de Maaker M.; Van Bockstal M.; Harbeck N.; Tung N.; Laudus N.; Sirtaine N.; Burchardi N.; Ternes N.; Savas P.; Radosevic-Robin N.; Gluz O.; Grimm O.; Nuciforo P.; Jank P.; Kirtani P.; Watson P.H.; Jelinic P.; Francis P.A.; Russell P.A.; Pruneri G.; Pierce R.H.; Hills R.; Leon-Ferre R.; de Wind R.; Shui R.; Leung S.; Tabbarah S.; Souza S.C.; O’Toole S.; Swain S.; Dillon D.A.; Dudgeon S.; Willis S.; Ely S.; Bedri S.; Irshad S.; Liu S.; Hendry S.; Bianchi S.; Bragança S.; Paik S.; Cheang M.C.U.; Luz S.; Gevaert T.; d’Alfons T.; John T.; Sugie T.; Kurkure U.; Bossuyt V.; Manem V.; Cámaea V.P.; Tong W.; Tutt A.; Tran W.T.; Wang Y.; Allory Y.; Husain Z.; Bago-Horvath Z.; the International Immuno-Oncology Biomarker Working Group; Hall J.A.; Kok M.; Horlings H.M.; Madabhushi A.; van der Laak J.; Ciompi F.; Laenkholm A.-V.; Bellolio E.; Gruosso T.; Fox S.B.; Araya J.C.; Floris G.; Hudeček J.; Voorwerk L.; Beck A.H.; Kerner J.; Larsimont D.; Declercq S.; Van den Eynden G.; Pusztai L.; Ehinger A.; Yang W.; AbdulJabbar K.; Yuan Y.; Singh R.; Hiley C.; Bakir M.; Lazar A.J.; Naber S.; Wienert S.; Castillo M.; Curigliano G.; Dieci M.-V.; André F.; Swanton C.; Reis-Filho J.; Sparano J.; Balslev E.; I-CHUN CHEN ; Stovgaard E.I.S.; Pogue-Geile K.; Blenman K.R.M.; Penault-Llorca F.; Schnitt S.; Lakhani S.R.; Vincent-Salomon A.; Rojo F.; Braybrooke J.P.; Hanna M.G.; Soler-Monsó M.T.; Bethmann D.; Castaneda C.A.; Willard-Gallo K.; Sharma A.; HUANG-CHUN LIEN ; Fineberg S.; Thagaard J.; Comerma L.; Gonzalez-Ericsson P.; Brogi E.; Loi S.; Saltz J.; Klaushen F.; Cooper L.; Amgad M.; Moore D.A.; Salgado R.; Hyytiäinen A.; Hida A.I.; Thompson A.; Lefevre A.; Gown A.; Lo A.; Sapino A. | npj Breast Cancer | 87 | 90 | |
2017 | Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer | SUNG-HSIN KUO ; Yang S.-Y.; You S.-L.; HUANG-CHUN LIEN ; CHING-HUNG LIN ; PO-HAN LIN ; CHIUN-SHENG HUANG | Oncotarget | 35 | 30 | |
2001 | Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer | BOR-CHING SHEU ; Lin R.-H.; HUANG-CHUN LIEN ; HONG-NERNG HO ; Hsu S.-M.; Huang S.-C. | Journal of Immunology | 176 | 156 | |
2006 | Primary brain T-cell lymphoma after kidney transplantation: a case report | Su I.-C.; HUANG-CHUN LIEN ; CHANG-MU CHEN | Surgical Neurology | 12 | 9 | |
2018 | Prognostic Significance of Clinicopathologic Features in Patients With Breast Ductal Carcinoma-in-Situ Who Received Breast-Conserving Surgery | SUNG-HSIN KUO ; Chiao Lo ; YU-HSUAN CHEN ; HUANG-CHUN LIEN ; WEN-HUNG KUO ; Wang, Ming-Yang; Lee, Yi-Hsuan; CHIUN-SHENG HUANG | Clinical Breast Cancer | 8 | 5 | |
2010 | Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide | Tseng H.-M.; LU-TING KUO ; HUANG-CHUN LIEN ; KAO-LANG LIU ; Liu M.-T.; CHAO YUAN HUANG | Anti-Cancer Drugs | 19 | 17 | |
2016 | PRRX2 as a novel TGF-β-induced factor enhances invasion and migration in mammary epithelial cell and correlates with poor prognosis in breast cancer | Juang Y.-L.; YUNG-MING JENG ; Chen C.-L.; HUANG-CHUN LIEN | Molecular Carcinogenesis | 26 | 22 | |
1999 | Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma | KUN-HUEI YEH ; HUANG-CHUN LIEN ; Hsu S.-M.; ANN-LII CHENG | American Journal of Hematology | 31 | | |